|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
N/A
|
National Institutes of Health
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,240,718
|
Alter, Blanche
|
DCEG (NCI)
|
|
Failed Tubulin Inhibitor Reformulated as Localized Adjuvant Therapy for Head and
|
N43CA140043-000
|
$223,412
|
"ROTHSTEIN, PH.D.", SAM
|
QRONO, INC.
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-11
|
$341,794
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Complications of Jaw Osteoradionecrosis in Cancer Management
|
5K22CA169089-03
|
$196,344
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$1,066,167
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
2P30CA138313-06
|
$1,495,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
1U10CA180790-01
|
$1,439,850
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
p90RSK2-Stathmin Signaling in Metastatic Human Cancers
|
1F31CA183365-01
|
$42,676
|
ALESI, GINA
|
EMORY UNIVERSITY
|
|
NCTN Deep South Research Consortium
|
1U10CA180855-01
|
$497,800
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
1U54CA190163-01
|
$678,281
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4
|
5R21CA180211-02
|
$162,452
|
ANDERSON, CAROLYN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Functions of Papillomavirus E6
|
5R01CA107394-11
|
$290,937
|
ANDROPHY, ELLIOT
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
1U10CA180828-01
|
$656,150
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Role of Osteoactivin in Invasion by Oral Cancers
|
5R21CA167126-02
|
$164,561
|
AROSARENA, ONEIDA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
|
1R01CA188430-01A1
|
$370,388
|
ASTSATUROV, IGOR
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Improving Self-management in Head and Neck Cancer
|
1R21CA178478-01A1
|
$221,198
|
BADR, HODA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
CD4+ Memory T-Cells in Human Tumor Microenvironment
|
5R01CA108970-10
|
$287,818
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA042014-25S1
|
$75,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-25S2
|
$33,333
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-25S3
|
$148,179
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-25
|
$1,505,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
|
5R01CA139633-05
|
$559,582
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Development and Evaluation of Purine and Coumarin Based Hsp90 Inhibitors
|
5U01CA120458-09
|
$326,800
|
BLAGG, BRIAN
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Lipid-based Nanocapsules and Triggered Chemotherapy
|
ZIA BC 010652
|
$312,486
|
Blumenthal, Robert
|
CCR (NCI)
|
|
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
|
5U01CA137026-05
|
$453,162
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
1U10CA180802-01
|
$639,550
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
1U10CA180844-01
|
$945,732
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Quantitative Imaging to Assess Response in Cancer Therapy Trials
|
5U01CA140206-05
|
$501,587
|
BUATTI, JOHN
|
UNIVERSITY OF IOWA
|
|
Translational Optimization of Bone Regeneration in the Irradiated Mandible
|
3R01CA125187-07S1
|
$91,406
|
BUCHMAN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
Translational Optimization of Bone Regeneration in the Irradiated Mandible
|
3R01CA125187-07S2
|
$56,602
|
BUCHMAN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
Translational Optimization of Bone Regeneration in the Irradiated Mandible
|
5R01CA125187-07
|
$237,398
|
BUCHMAN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
The Dynamics of Smoking Cessation After Cancer Diagnosis: A Naturalisitic Study
|
1K07CA181351-01A1
|
$153,747
|
BURRIS, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
1U10CA180867-01
|
$1,302,200
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA016058-38S1
|
$75,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S2
|
$125,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S3
|
$135,233
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S4
|
$149,838
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Innate Immunity: Elucidation and Modulation for Cancer Therapy
|
5P01CA095426-13
|
$1,986,616
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-38
|
$4,444,835
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|